Effect of Micardis on the expression of renal medulla aquaporin-2 in diabetic mice

Lijun Yao , Jianqing Wang , Anguo Deng , Jianshe Liu , Hong Zhao

Current Medical Science ›› 2008, Vol. 28 ›› Issue (9) : 272 -275.

PDF
Current Medical Science ›› 2008, Vol. 28 ›› Issue (9) : 272 -275. DOI: 10.1007/s11596-008-0309-0
Article

Effect of Micardis on the expression of renal medulla aquaporin-2 in diabetic mice

Author information +
History +
PDF

Abstract

In current study, the effect of angiotensin receptor blocker Micardis on the localization and expression of aquaporin-2 (AQP2) was investigated in the renal medullary collecting duct of mice with diabetic nephropathy (DN). Mice were divided into three groups: normal group, DN group and Micardis-treated group. Six weeks after establishment of STZ-induced DN model in mice, the expression of AQP2 in renal medulla was detected measured by semiquantitative immunofluorescence histochemistry and Western blot techniques, and the localization of AQP2 by confocal immunofluorescence laser scanning microscopy. The results showed that the urinary osmolality was decreased in DN group as compared with normal group (2.39±0.11 vs 3.16±0.16, P<0.05). Although the localization of AQP2 on the renal medulla was unchanged, the expression of AQP2 was increased significantly in DN group as compared with normal group. Micardis could partly attenuate above changes. It was concluded that treatment with Micardis could partly rectify the abnormal expression of AQP2 in renal medulla of DN mice, which suggested that rennin-angiotensin system (RAS) is implicated in the pathogenesis of DN by regulating the expression of AQP2.

Keywords

diabetic nephropathy / aquaporin 2 / Micardis / mouse

Cite this article

Download citation ▾
Lijun Yao, Jianqing Wang, Anguo Deng, Jianshe Liu, Hong Zhao. Effect of Micardis on the expression of renal medulla aquaporin-2 in diabetic mice. Current Medical Science, 2008, 28(9): 272-275 DOI:10.1007/s11596-008-0309-0

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

MuX., KangB.. Aquaporins and diabetic nephropathy. Intern J Endocrinol Metab, 2006, 26(3): 113-115

[2]

YaoL. J., ZhaoH., DengA. G., et al.. Study on the mechanism of protein kinase C alpha in mediating urine concentration ability. Chin J Nephr (Chinese), 2006, 22(11): 693-696

[3]

DuJ., ZhangS. H.. Expression of aquaporin-2 in renal medulla of diabetic rats and its significance. Chin J Endocrinol Metab (Chinese), 2006, 22(1): 67-71

[4]

NielsenS., FrokiaerJ., MarplesD., et al.. Aquaporins in the kidney: from molecules to medicine. Physiol Rev, 2002, 82(1): 205-244

[5]

KimD., SandsJ. M., KleinJ. D.. Changes in renal medullary transport proteins during uncontrolled diabetes mellitus in rats. Am J Physiol Renal Physiol, 2003, 285(2): F303-F309

[6]

BickelC. A., KnepperM. A., VerbalisJ. G., et al.. Dysregulation of renal salt and water transport proteins in diabetic Zucker rats. Kidney Int, 2002, 61(6): 2099-2110

[7]

FanY. P., JiangJ. J.. Aquaporin and kidney. Guowai Yixue Miniao Xitong Fence (Chinese), 2001, 21(5): 215-218

[8]

KimS. W., JeonY. S., LeeJ. U., et al.. Diminished adenylate cyclase activity and aquaporin 2 expression in acute renal failure rats. Kidney Int, 2000, 57(4): 1643-1650

[9]

KwonT. H., FrokiaerJ., KnepperM. A., et al.. Reduced AQP1, 2 and 3 levels in kidneys of rats with CRF induced by surgical reduction in renal mass. Am J Physiol, 1998, 275(5): F724-F741

[10]

Jiang R Y, Xu D L, Lai W Y et al. Effect of captopril and losartan on expression of kidney aquaporin-2 mRNA and urine aquaporin-2 excretion in rats. J First Mil Med Univ (Chinese), 2005(4):391–394

[11]

LeeY. J., SongI. K., JangK. J., et al.. Increased AQP2 targeting in primary cultured IMCD cells in response to angiotensin II through AT1 receptor. Am J Physiol Renal Physiol, 2007, 292(1): F340-F350

[12]

YuC. M., Wing Hon LaiK., LiP. S., et al.. Normalization of renal aquaporin-2 water channel expression by fosinopril, valsartan, and combination therapy in congestive heart failure: a new mechanism of action. J Mol Cell Cardiol, 2004, 36(3): 445-453

[13]

KwonT. H., NielsenJ., KnepperM. A., et al.. Angiotensin II AT1 receptor blockade decreases vasopressin-induced water reabsorption and AQP2 levels in NaCl-restricted rats. Am J Physiol Renal Physiol, 2005, 288(4): F673-F684

[14]

KleinJ. D., MurrellB. P., TuckerS., et al.. Urea transporter UT-A1 and aquaporin-2 proteins decrease in response to angiotensin II or norepinephrine-induced acute hypertension. Am J Physiol Renal Physiol, 2006, 291(5): F952-F959

[15]

PechV., KleinJ. D., KozlowskiS. D., et al.. Vasopressin increases urea permeability in the initial IMCD from diabetic rats. Am J Physiol Renal Physiol, 2005, 289(3): F531-F535

AI Summary AI Mindmap
PDF

89

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/